Clear All
12611 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
70095-0059-01 70095-0059 Pomalidomide Pomalidomide 3.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 31, 2026 In Use
43598-0517-21 43598-0517 Pomalidomide Pomalidomide 4.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 31, 2026 In Use
43598-0518-21 43598-0518 Pomalidomide Pomalidomide 3.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 31, 2026 In Use
72579-0025-01 72579-0025 Sonrotoclax BEQALZI 20.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Aug 31, 2026 In Use
70095-0057-02 70095-0057 Pomalidomide Pomalidomide 1.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 31, 2026 In Use
69097-0037-07 69097-0037 Pomalidomide Pomalidomide 2.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0038-07 69097-0038 Pomalidomide Pomalidomide 3.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0037-81 69097-0037 Pomalidomide Pomalidomide 2.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0038-81 69097-0038 Pomalidomide Pomalidomide 3.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0039-07 69097-0039 Pomalidomide Pomalidomide 4.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0039-81 69097-0039 Pomalidomide Pomalidomide 4.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0036-07 69097-0036 Pomalidomide Pomalidomide 1.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
69097-0036-81 69097-0036 Pomalidomide Pomalidomide 1.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Aug 30, 2026 In Use
85219-0101-01 85219-0101 Daraxonrasib RASONQUE 100.0 mg/1 Chemotherapy RAS Inhibitor KRAS, NRAS, HRAS Oral Aug 26, 2026 In Use
85219-0104-01 85219-0104 Daraxonrasib RASONQUE 150.0 mg/1 Chemotherapy RAS Inhibitor KRAS, NRAS, HRAS Oral Aug 26, 2026 In Use
70518-4293-07 70518-4293 PREDNISONE Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 25, 2026 In Use
72789-0473-15 72789-0473 PredniSONE PredniSONE Tablets, USP, 20 mg 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 21, 2026 In Use
68788-4182-05 68788-4182 PredniSONE PredniSONE 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
68788-4182-08 68788-4182 PredniSONE PredniSONE 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
71335-2160-06 71335-2160 Prednisone Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
68788-4182-01 68788-4182 PredniSONE PredniSONE 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
71335-1780-09 71335-1780 Prednisone Prednisone 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
71335-2160-04 71335-2160 Prednisone Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
68788-4182-04 68788-4182 PredniSONE PredniSONE 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use
71335-2160-01 71335-2160 Prednisone Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug 20, 2026 In Use

Found 12611 results — Export these results